United Biotech Private Limited — Bortezomib Exporter Profile
Indian Pharmaceutical Exporter · #12 for Bortezomib · $143.6K export value · DGFT Verified
United Biotech Private Limited is the #12 Indian exporter of Bortezomib with $143.6K in export value and 19 verified shipments. United Biotech Private Limited holds a 0.7% market share in Bortezomib exports across 4 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.
United Biotech Private Limited — Bortezomib Export Profile: Buyers & Destinations
Where Does United Biotech Private Limited Export Bortezomib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $72.0K | 7 | 50.2% |
| PAKISTAN | $67.7K | 8 | 47.1% |
| ARMENIA | $2.3K | 2 | 1.6% |
| KENYA | $1.5K | 2 | 1.1% |
United Biotech Private Limited exports Bortezomib to 4 countries. The largest destination is SRI LANKA accounting for 50.2% of United Biotech Private Limited's Bortezomib shipments, followed by PAKISTAN (47.1%) and ARMENIA (1.6%). These destinations reflect United Biotech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bortezomib from United Biotech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SONERI BANK | PAKISTAN | $67.7K | 8 |
| NATIONAL DEVELOPMENT BANK PLC | SRI LANKA | $62.9K | 3 |
| TRADE SERVICES | SRI LANKA | $3.9K | 1 |
| TRADE SERVICES DFCC BANK PLC | SRI LANKA | $3.0K | 2 |
| GEORGE STEUART HEALTH (PVT.)LTD | SRI LANKA | $2.2K | 1 |
| VIOLETA MEDICAL CENTRE LTD. | ARMENIA | $1.9K | 1 |
| SALAMA PHARMACEUTICALS LIMITED | KENYA | $1.5K | 2 |
| VIOLETA MEDICAL CENTRE LLC | ARMENIA | $476 | 1 |
United Biotech Private Limited supplies Bortezomib to 8 buyers globally. The largest buyer is SONERI BANK (PAKISTAN), followed by NATIONAL DEVELOPMENT BANK PLC (SRI LANKA) and TRADE SERVICES (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bortezomib Export Value and How Much Does United Biotech Private Limited Contribute?
India exported $13.7M worth of Bortezomib through 1,383 shipments from 200 suppliers to 109 countries, serving 498 buyers globally. United Biotech Private Limited contributes $143.6K to this total, accounting for 0.7% of India's Bortezomib exports. United Biotech Private Limited ships Bortezomib to 4 countries through 8 buyers.
What Is the Average Shipment Value for United Biotech Private Limited's Bortezomib Exports?
United Biotech Private Limited's average Bortezomib shipment value is $7.6K per consignment, based on 19 shipments totaling $143.6K. The largest destination is SRI LANKA (50.2% of United Biotech Private Limited's Bortezomib exports).
How Does United Biotech Private Limited Compare to Other Indian Bortezomib Exporters?
United Biotech Private Limited ranks #12 among 200 Indian Bortezomib exporters with a 0.7% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($3.6M), EUGIA PHARMA SPECIALITIES LIMITED ($3.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.9M). United Biotech Private Limited processed 19 shipments to 4 destination countries.
What Bortezomib Formulations Does United Biotech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EGYBORT 2 BORTEZOMIB FOR INJECTION IP 2M | $62.9K | 3 |
| EGYBORT BORTEZOMIB FOR INJECTION 3.5 MGBATCH NO:BOLJ3B7 MANUFACTURING DT:10/2023EXP DT:09/2025 | $15.0K | 1 |
| PHARMA PRODUCT-EGYBORT 3.5(BORTEZOMIB FO | $12.7K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS - EGYBORTBORTEZOMIB INJECTION 3.5 MG , BATCHNO.BOLD4B1 , MFG. DATE 04/2024 EXP. DATE300 | $8.9K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS, EGYBORT, BORTEZOMIB FOR INJECTION 3.5MG, BATCH. BOLL4B2, MFG:12/2024 EXP:11/2026 | $8.6K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS EGYBORT Bortezomib for Injection 3.5 mg, B.NO:BOLA5C2, MFG: 01/2025, EXP: 12/2026 | $8.6K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS, EGYBORT, BORTEZOMIB FOR INJECTION 1.0MG, BATCH.BOLL4C1, MFG:12/2024, EXP:11/2026 | $6.9K | 1 |
| EGYBORT 2 INJECTION BORTEZOMIB FOR INJ IP 2 0 MG LYOPHILIZED B NO BOLD5B1 M 04 25 E 03 27 | $3.9K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS - EGYBORTBORTEZOMIB INJECTION 1.0 MG , BATCHNO. BOLE4C1 , MFG. DATE 05/2024 EXP.DATE299 | $3.6K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS EGYBORT Bortezomib for Injection 1.0 mg, B.NO:BOLA5A1, MFG: 01/2025, EXP: 12/2026 | $3.4K | 1 |
United Biotech Private Limited exports 16 distinct Bortezomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EGYBORT 2 BORTEZOMIB FOR INJECTION IP 2M with 3 shipments worth $62.9K.
How Does United Biotech Private Limited Compare to Nearest Bortezomib Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | VEXXA LIFESCIENCES PVT. LTD. | $166.6K | 14 | 1 | $11.9K |
| 8 | GLENMARK PHARMACEUTICALS LIMITED | $150.0K | 3 | 2 | $50.0K |
| 12 | UNITED BIOTECH PRIVATE LIMITED ★ | $143.6K | 19 | 4 | $7.6K |
| 13 | MILES INTERNATIONAL | $129.4K | 28 | 3 | $4.6K |
| 14 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $125.3K | 11 | 4 | $11.4K |
United Biotech Private Limited ranks #12 among 200 Indian Bortezomib exporters. Average shipment value of $7.6K compared to the market average of $68.4K. The closest competitors by value are VEXXA LIFESCIENCES PVT. LTD. and GLENMARK PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Bortezomib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 263 | 19.0% |
| SAHAR AIR | 229 | 16.6% |
| DELHI AIR CARGO ACC (INDEL4) | 168 | 12.1% |
| DELHI AIR | 148 | 10.7% |
| HYDERABAD ACC (INHYD4) | 82 | 5.9% |
| HYDERABAD AIR | 82 | 5.9% |
| Bombay Air | 62 | 4.5% |
| Bombay Air Cargo | 32 | 2.3% |
What Other Advanced Oncology Products Does United Biotech Private Limited Export?
United Biotech Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on United Biotech Private Limited's Bortezomib Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)
United Biotech Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.
The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.
About United Biotech Private Limited
United Biotech Private Limited exports 30 products worth $7.0M. Beyond Bortezomib, top products include Ertapenem, Doxorubicin, Voriconazole, Cisplatin, Methylprednisolone. View the complete United Biotech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bortezomib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching United Biotech Private Limited exporting Bortezomib, covering 16 formulations to 4 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 498+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bortezomib Export Data from United Biotech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for United Biotech Private Limited's Bortezomib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
United Biotech Private Limited
Full Company Profile →
30 products · $7.0M total trade · 7 categories
Bortezomib Stats
Company Overview
Top Products by United Biotech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for United Biotech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bortezomib. For current shipment-level data, contact TransData Nexus.